Coral Laboratories Ltd
BSE:524506
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Coral Laboratories Ltd
Revenue
Coral Laboratories Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Coral Laboratories Ltd
BSE:524506
|
Revenue
₹875.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Revenue
₹346.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Cipla Ltd
NSE:CIPLA
|
Revenue
₹283.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Revenue
₹568.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Revenue
₹261.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Revenue
₹127.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
7%
|
|
Coral Laboratories Ltd
Glance View
Coral Laboratories Ltd. engages in the manufacture of pharmaceutical formulations. The company is headquartered in Mumbai, Maharashtra. The Company’s geographical segments include Ethiopia, India and Rest of World. The firm's dosage forms include tablets, capsules, ointments and creams, liquid orals, b-lactam, topical preparations, eye/ ear drops, nasal sprays, dry syrup and injectables. The firm offers its products in various therapeutic areas, including antibiotics/antibacterial, anti fungals, gastro-intestinal drugs, anti-emetics, analgesic/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, antiprotozoal/antiamoebic, anticold, herbal medicine, topical preparations, appetizer, oral antiseptic preparations, antimalarial drugs, cough suppressant/expectorant and mouthwash. The Company’s manufacturing facilities are located at Daman and Dehradun. The company provides a range of nutraceutical products, such as dietary supplements, herbal / phytochemicals, multivitamins and nutrients.
See Also
What is Coral Laboratories Ltd's Revenue?
Revenue
875.6m
INR
Based on the financial report for Dec 31, 2025, Coral Laboratories Ltd's Revenue amounts to 875.6m INR.
What is Coral Laboratories Ltd's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -24%.
